Safety and Antitumour Activity of ODM-201 (BAY-1841788) in Castration-resistant, CYP17 Inhibitor-naïve Prostate Cancer: Results from Extended Follow-up of the ARADES Trial
Fizazi, Karim, Massard, Christophe, Bono, Petri, Kataja, Vesa, James, Nicholas, Tammela, Teuvo L., Joensuu, Heikki, Aspegren, John, Mustonen, MikaLanguage:
english
Journal:
European Urology Focus
DOI:
10.1016/j.euf.2017.01.010
Date:
February, 2017
File:
PDF, 1.56 MB
english, 2017